Skip to content

sublingual immunotherapy for Japanese cedar pollinosis

sublingual immunotherapy for Japanese cedar pollinosis - SLIT for JCP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000016532
Enrollment
200
Registered
2015-02-16
Start date
2006-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese cedar pollinosis

Interventions

Using the standardized cedar pollen extract, sublingual immunotherapy(sublingual-spit) is performed. Gradually increasing the extract, to reach the maintenance dose after one month.

Sponsors

Bureau of social welfare and public health, Tokyo Metropolitan Goverment
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1,There is rhinitis symptoms in more than three years during cedar pollen season 2,Intradermal test positive or IgE antibody-positive against cedar pollen 3,People who can participate in the test for 3 years in the voluntary

Exclusion criteria

Exclusion criteria: 1,People that have merged with other nose disease 2,People who are using the drug for allergic disease 3,People who have oral steroid 4,People with a history of asthma 5,People who are pregnant 6,People who are breast-feeding 7,People who have serious complications 8,People who doctor has determined unsuitable

Design outcomes

Primary

MeasureTime frame
symptom medication score, QOL score

Secondary

MeasureTime frame
Serum cytokines

Countries

Japan

Contacts

Public ContactMinoru Gotoh

Nippon Medical School otorhinolaryngology

m.gotoh@nms.ac.jp03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026